VAERS Explorer
Back to explore

Report #2858927

Received Sep 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
1 yrs
State
IL
Recovered
Unknown
Vaccinated
Jul 8, 2025
Onset
Jul 1, 2025
Days to onset
—
Hospital days
—

Vaccines (3)

TypeNameManufacturerDoseLotRoute / Site
HEPAHEP A (HAVRIX)GLAXOSMITHKLINE BIOLOGICALSUNK——
MMRMEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.UNKY008289RL
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.UNK——

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

No additional AE case reported.; HCP stated MMR II was inadvertently administered during a T/E on 7/09/2025.; HCP stated MMR II was inadvertently administered during a T/E on 7/09/2025.; This spontaneous report was received from a Physician Assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were not reported. On 09-Jul-2025, the patient was inadvertently vaccinated with an improperly stored dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) 0.5 mL (route of administration and anatomical location were not reported) lot # Y008289 has been verified to be valid and expiration date: 24-Apr-2026, reconstituted with sterile diluent solution for injection (lot# and expiry date were not reported) as Prophylaxis. Temperature excursion(TE) was 9.69 degree Celsius (C) for 15 minutes. No previous TE nor additional adverse events were reported. This is one of four reports from the same reporter. Follow-up information has been received from medical assistant on 10-Sep-2025 via telephone memo. Patient's demographics were added. The 1-year-old male patient had the vaccine administration on 07-Jul-2025 (Conflicting information as temperature excursion occurred on 09-Jul-2025) in left thigh. On the same date, the patient also received Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (+) sterile diluent (strength, dose, frequency, route of administration, site of administration, lot #, and expiration date were not provided); and other company suspect vaccine: Hepatitis a vaccine inact (HAVRIX) (strength, dose, frequency, route of administration, site of administration, lot #, and expiration date were not provided). No vaccines were administered in previous 4 weeks and no illness at time of vaccination. Additional information is not expected.

Other medications

MMR - STERILE DILUENT; VARIVAX - STERILE DILUENT